Stigma toward substance dependence: Causes, consequences, and potential interventions

AC Krendl, BL Perry - Psychological Science in the Public …, 2023 - journals.sagepub.com
Substance dependence is a prevalent and urgent public health problem. In 2021, 60 million
Americans reported abusing alcohol within the month prior to being surveyed, and nearly 20 …

“I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm

L Cox, T Piatkowski, J McVeigh - Drugs: Education, Prevention and …, 2024 - Taylor & Francis
Background This investigation explores the concept of stigma related to people who use
anabolic-androgenic steroids (PWU-AAS) when accessing healthcare services. Anabolic …

Caring for our patients with opioid use disorder in the perioperative period: a guide for the anesthesiologist

AM Barreveld, A Mendelson, B Deiling… - Anesthesia & …, 2023 - journals.lww.com
BACKGROUND TO OPIOID USE DISORDER, TREATMENT PRINCIPLES, AND THE
ANESTHESIOLOGIST OUD is defined by the overpowering desire to obtain and use opioids …

Evolution of an epidemic: Understanding the opioid epidemic in the United States and the impact of the COVID-19 pandemic on opioid-related mortality

R Laing, CA Donnelly - Plos one, 2024 - journals.plos.org
We conduct this research with a two-fold aim: providing a quantitative analysis of the opioid
epidemic in the United States (US), and exploring the impact of the COVID-19 pandemic on …

Public Health Interventions and Overdose-Related Outcomes Among Persons With Opioid Use Disorder

N Nataraj, SM Rikard, K Zhang, X Jiang… - JAMA Network …, 2024 - jamanetwork.com
Importance Given the high number of opioid overdose deaths in the US and the complex
epidemiology of opioid use disorder (OUD), systems models can serve as a tool to identify …

Community-level determinants of stakeholder perceptions of community stigma toward people with opioid use disorders, harm reduction services and treatment in the …

A Davis, KL Stringer, ML Drainoni, CB Oser… - International Journal of …, 2023 - Elsevier
Background Community stigma toward people with opioid use disorder (OUD) can impede
access to harm reduction services and treatment with medications for opioid use disorder …

[HTML][HTML] “A Lack of Empathy:” A qualitative study of Black people seeking treatment for opioid use disorder

UG Khatri, MJN Tiako, A Gebreyesus, A Reid… - … -Qualitative Research in …, 2023 - Elsevier
Racial inequities in the treatment of opioid use disorder (OUD) are an urgent and insidious
issue, especially in the context of the national opioid overdose crisis. Medications for opioid …

Patient-provider shared decision-making, trust, and opioid misuse among US veterans prescribed long-term opioid therapy for chronic pain

VC Somohano, CL Smith, S Saha, S McPherson… - Journal of general …, 2023 - Springer
Background Patient-provider shared decision-making is associated with better treatment
adherence and pain outcomes in opioid-specific pain management. One possible …

Public health impact and harm reduction implications of xylazine-involved overdoses: a narrative review

DT Zhu - Harm Reduction Journal, 2023 - Springer
Introduction Xylazine, an α2-adrenoceptor agonist sedative commonly used in veterinary
medicine, is not approved for human use. Nevertheless, xylazine-involved overdose rates …

Quantifying stigma effects: The influence of stigma and pharmacist implicit attitudes on opioid agonist treatment consumer well-being.

T Caruana - Stigma and Health, 2024 - psycnet.apa.org
Opioid agonist treatment (OAT) is subject to stigma due to its association with criminalized
and socially discredited illicit drug use behaviors. This study aimed to explore if the negative …